Advancing an imperative global discussion on pharma development in the Middle East and North Africa, Marwan Abdulaziz Janahi, Executive Director of TECOM Investments' Science Cluster in Dubai will participate in a panel discussion at The BIO International Convention (BIO 2014). Titled "Healthcare Competitiveness and New Opportunities for R&D in the Middle East and North Africa", the panel will be held on Wednesday, June 25, 2014 in the Emerging Opportunities in Global Markets Forum.
The TECOM Investments' Science Cluster comprises of DuBiotech, a Free Zone Business Park dedicated to fostering the growth of the life sciences industry and EnPark, a place designed to drive the growth of the alternative energy and environmental industries in the MENA region.
The panel discussion will explore healthcare competitiveness and opportunities for R&D in the Middle East and North Africa (MENA), which has seen a recent influx of investment across the healthcare spectrum. Mr. Abdulaziz's presentation will focus on:
Increasing emphasis on healthcare by governments and growing business opportunities throughout MENA
Importance of R&D in the region
Recent enhancements for R&D in specific countries
TECOM Investments' Science Cluster provides access to peer companies and regulators, significant industry knowledge and a state-of-the-art real estate platform for life science and sustainability businesses looking to set up operations or expand their presence in the Middle East. DuBiotech features a community of biotechnology, pharmaceutical and research companies including Pfizer, Amgen, Merck Serono and Genzyme.
The BIO International Convention is hosted by the Biotechnology Industry Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centres and related organizations across the United States and in more than 30 other nations. This year's event is being held in San Diego, California from June 23-26.
